Format

Send to

Choose Destination
Int J Cardiol. 2019 Feb 25. pii: S0167-5273(18)36875-X. doi: 10.1016/j.ijcard.2019.02.030. [Epub ahead of print]

Microvascular complications in diabetes: A growing concern for cardiologists.

Author information

1
Department Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, Italy. Electronic address: angelo.avogaro@unipd.it.
2
Department Medicine, Section of Diabetes and Metabolic Diseases, University of Padova, Italy.

Abstract

Randomized, cross-sectional, and prospective studies have demonstrated that microvascular complications in patients with diabetes are not only the cause of blindness, renal failure and non-traumatic amputations, but also powerful predictors of cardiovascular complications. Beside the metabolic theory, the pathophysiology of diabetic microvascular complications is determined by the interaction among several factors, including epigenetic modifications and the reduced release of progenitor cells by the bone marrow, that contribute simultaneously to damage and impaired vascular protection against hyperglycemia. Identifying and preventing microvascular complications has the significant potential to reduce major adverse cardiovascular events. For these reasons, there may no longer be a rational to consider microangiopathy and macroangiopathy as entirely separate entities, but they should most likely be viewed as a continuum of the widespread vascular damage determined by diabetes mellitus.

KEYWORDS:

Coronary heart disease; Diabetes mellitus; Heart failure; Microvascular complications

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center